2026 Medicare pricing guide
How Much Does GLP-1 Coverage Cost on Medicare?
If you qualify for the temporary Medicare GLP-1 Bridge, your copay is a flat $50 a month. If you don't, you're either routed through your regular Part D drug plan's normal cost-sharing or paying a manufacturer's cash price directly — and neither of those has one clean number, no matter what a headline promises you.
Last fact-checked: July 20, 2026
Compare the three ways GLP-1s get priced on Medicare
Read this table before you read anything else on the page. It's the whole guide, condensed.
| Question | Medicare GLP-1 Bridge | Normal Part D | Cash / self-pay |
|---|---|---|---|
| Monthly cost | Flat $50, any income | Set by your plan's tier and deductible — no single number is honest | Set directly by the manufacturer, and it changes |
| Who qualifies | Everyone who meets every Bridge rule (Part D type, BMI/condition route, no excluded diagnosis) | Anyone whose GLP-1 is covered under their own plan's formulary — including the people the Bridge excludes | Anyone, regardless of coverage |
| Covered products | Foundayo tablet, Wegovy injection or tablet, Zepbound KwikPen only | Whatever your specific plan's formulary lists | Whatever the manufacturer's direct program sells |
| Counts toward deductible or OOP max? | No | Yes, under standard Part D rules | N/A — no insurance is involved |
| How long is this available | Temporary pilot, July 1, 2026 – December 31, 2027 only | Ongoing, year to year, under your plan | Ongoing, on whatever terms the manufacturer sets |
Sources: CMS; Medicare Fact Sheet, Product No. 12234; Medicare.gov: weight-loss drugs
What you pay under the Medicare GLP-1 Bridge
The Bridge is a short-term CMS demonstration, not a permanent change to Medicare drug law. It began July 1, 2026 and is scheduled to end December 31, 2027. Inside that window, if you clear every eligibility rule, your copay is a flat $50 a month. That is the same $50 whether you're on a fixed income or not. Source: CMS
The $50 doesn't behave like a normal copay
It doesn't count toward your Part D deductible or out-of-pocket maximum, there's no low-income subsidy version of it, and it can't be spread across months through the Medicare Prescription Payment Plan. It's a flat $50, full stop, or it doesn't apply to you at all. Source: Medicare Fact Sheet, Product No. 12234
The $50 only buys you one of three specific products: Foundayo tablets, Wegovy (injection or tablet), or the Zepbound KwikPen. Zepbound's single-dose pens and vials aren't included, and neither is Ozempic or any compounded semaglutide or tirzepatide. Ask for the wrong formulation and the $50 price never comes up at all. Source: Medicare.gov: weight-loss drugs
Eligibility is a full checklist, not a single test. You need Part D coverage that isn't a private fee-for-service plan, cost plan, or PACE program; you can't already be getting a GLP-1 through Part D; you need to be 18 or older with a BMI of at least 35, or a BMI of 30–34.99 plus a condition like heart failure or chronic kidney disease, or a BMI of 27–29.99 plus prediabetes or a prior heart attack, stroke, or peripheral artery disease. Source: Medicare.gov: weight-loss drugs
What you pay under normal Part D (no Bridge)
Here's the detail that pricing headlines skip: a meaningful share of people asking about GLP-1 cost on Medicare were never going to see the $50 Bridge price at all, because their situation routes through ordinary Part D instead.
That includes anyone who has type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease. The Bridge explicitly excludes those conditions, and says the GLP-1 may instead be covered through the person's regular Part D drug plan. It also includes anyone who's already getting a GLP-1 through Part D before the Bridge existed. Source: Medicare.gov: weight-loss drugs
Why we won't quote you a number here
Normal Part D cost-sharing depends on your plan's specific formulary tier, your deductible, and where you are in the coverage year — three variables that are different for every plan and every person. Any single dollar figure printed on a page like this one would be true for approximately nobody. Call your plan or check its formulary directly for your real number.
What you pay in cash, without either
If you're not Bridge-eligible and your plan doesn't cover your GLP-1, the manufacturers run their own direct-to-patient cash programs: NovoCare Pharmacy for Wegovy, and LillyDirect for Zepbound. Both exist specifically for people paying without insurance.
We're not going to hand you a number here either. Manufacturer cash pricing is set unilaterally, changes without much notice, and varies by dose and by which specific program tier you land in — the same trap as the "average lawyer fee" figures you see on other pricing pages that turn out to be nobody's actual bill. Go to the source directly: novocare.com for Wegovy, or pricinginfo.lilly.com/zepbound for Zepbound. Whatever number is posted there today is the only one worth trusting.
One thing that doesn't change: manufacturer savings cards need commercial insurance
If a program advertises a coupon-style price, read the fine print before you assume it applies to you on Medicare. Manufacturer copay-savings cards are generally built for people with commercial insurance, and the Medicare cash-pay programs above are the ones actually built for beneficiaries paying out of pocket.
Which bucket are you actually in?
Work through this in order. Stop at the first line that's true for you.
- Do you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease? You're in normal Part D, not the Bridge — check your plan's formulary.
- Are you already getting a GLP-1 through your Part D plan? Same answer: normal Part D, not the Bridge.
- Do you have Part D coverage (not PFFS, cost plan, or PACE), age 18+, and one of the BMI-plus-condition combinations above? You're likely Bridge-eligible — ask your prescriber to check.
- None of the above fit, or your plan won't cover the drug? You're looking at the manufacturer's cash-pay route — go check the current price directly.
Frequently asked questions
Is the Medicare GLP-1 Bridge $50 a month forever?
No. The Bridge is a temporary CMS demonstration running from July 1, 2026 through December 31, 2027. It is not a permanent Medicare benefit, and the underlying Part D exclusion for weight-loss drugs still applies outside the pilot.
Does the $50 Bridge copay count toward my Part D deductible?
No. The $50 copay does not count toward your Part D deductible or out-of-pocket maximum, and it isn't eligible for the low-income subsidy or the Medicare Prescription Payment Plan.
Why don't I qualify for the $50 Bridge price?
The most common reasons are having type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (those route through normal Part D instead), already getting a GLP-1 through Part D, or not meeting the age, BMI, or condition combination the Bridge requires.
Does the Bridge cover Ozempic?
No. The Bridge's covered list is Foundayo tablet, Wegovy injection or tablet, and the Zepbound KwikPen only. Ozempic, Zepbound single-dose pens or vials, and compounded GLP-1 products are excluded.
How much does normal Part D cost-sharing come to for a GLP-1?
It depends entirely on your specific plan's formulary tier, your deductible, and where you are in the plan year. There is no single figure that applies across plans; check your plan's formulary or call it directly.
How much is Wegovy or Zepbound in cash without insurance?
The manufacturers set and change this price directly through NovoCare Pharmacy (Wegovy) and LillyDirect (Zepbound). Check their current pricing pages rather than relying on a number printed elsewhere, since these change.
Can I use a manufacturer savings card with Medicare?
Manufacturer copay-savings cards are generally built for people with commercial insurance, not Medicare. The cash-pay programs built specifically for Medicare beneficiaries are NovoCare Pharmacy and LillyDirect.
What if I think I qualify for the Bridge but my plan denies it?
It depends on who said no. If the Bridge turned down the prior authorization, there is no appeal: CMS says there is no appeals process under the Medicare GLP-1 Bridge, and your prescriber can only resubmit the request with corrected or added information. If your Part D plan denied a GLP-1 that Part D covers (for example, for type 2 diabetes), that is a coverage decision you can appeal. See our companion guide on the GLP-1 denial appeal ladder for the exact steps and deadlines. Source: CMS: Bridge information for providers